Mayo Clinic Tests Magnetic Heating to Fight Cancer

New experimental approach uses nanoparticles and electromagnetic fields to target and destroy solid tumors.

Published on Feb. 21, 2026

Got story updates? Submit your updates here. ›

Mayo Clinic is the first in the U.S. to test a new technology that uses heat to target and destroy solid tumors. The process involves injecting iron-containing magnetic nanoparticles into the bloodstream, which bind to cancer cells. An electromagnetic field is then applied, causing the nanoparticles to heat up and destroy the cancer cells while minimizing damage to surrounding healthy tissue.

Why it matters

This investigational treatment represents a significant step forward in cancer research, as it offers a more targeted and less invasive approach compared to traditional chemotherapy and radiation. If successful, it could improve outcomes for patients with difficult-to-treat cancers.

The details

The core of this technology lies in the use of iron-containing magnetic nanoparticles. These microscopic particles are injected into the bloodstream and designed to bind specifically with cancer cells. Once the nanoparticles accumulate in the tumor, an electromagnetic field is applied, causing the nanoparticles to heat up and generate localized hyperthermia that destroys the cancer cells. The system is carefully controlled to maintain a temperature of no more than 50 degrees Celsius (122 degrees Fahrenheit), minimizing damage to surrounding healthy tissue.

  • Mayo Clinic is the first in the U.S. to test this new technology.

The players

Mayo Clinic

A nonprofit organization committed to clinical practice, education, and research, headquartered in Rochester, Minnesota.

Dr. Scott Lester

A radiation oncologist at Mayo Clinic who is leading the clinical trial to assess the safety of this innovative technique.

New Phase Ltd.

A company that collaborated with Mayo Clinic to develop the magnetic nanoparticle-based hyperthermia technology.

Got photos? Submit your photos here. ›

What they’re saying

“Temperature is the Achilles' heel of cancer.”

— Dr. Scott Lester, Radiation Oncologist, Mayo Clinic

What’s next

The initial focus of the research is on evaluating the safety, feasibility, and potential effectiveness of this method in treating advanced cancers. If successful, the technology could be explored for a wider range of solid tumors.

The takeaway

This innovative approach to cancer treatment using magnetic nanoparticles and targeted hyperthermia represents a significant advancement in the field, offering the potential for a more precise and less invasive option compared to traditional therapies. The successful implementation of this technology at Mayo Clinic could pave the way for further advancements in personalized cancer care.